MX2019002334A - Medicamentos con sabor y experiencia sensorial mejorados. - Google Patents

Medicamentos con sabor y experiencia sensorial mejorados.

Info

Publication number
MX2019002334A
MX2019002334A MX2019002334A MX2019002334A MX2019002334A MX 2019002334 A MX2019002334 A MX 2019002334A MX 2019002334 A MX2019002334 A MX 2019002334A MX 2019002334 A MX2019002334 A MX 2019002334A MX 2019002334 A MX2019002334 A MX 2019002334A
Authority
MX
Mexico
Prior art keywords
medication
sensory experience
improved taste
liquid medication
taste
Prior art date
Application number
MX2019002334A
Other languages
English (en)
Inventor
Jean NAUGHTON Valerie
NEWTON Jason
FINDLEY Molly
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2019002334A publication Critical patent/MX2019002334A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Abstract

Un medicamento líquido en una botella que comprende de tres a cuatro activos farmacéuticos seleccionados del grupo que consiste en guaifenesina, acetaminofén, dextrometorfano, fenilefrina, sales farmacéuticamente aceptables de estos y combinaciones de estos, acetato de etilo 3-(p-mentano-3 carboxamido) y mentol. El medicamento líquido puedeproporcionar un sabor y una experiencia sensorial que atraiga a los consumidores.
MX2019002334A 2016-09-01 2017-08-31 Medicamentos con sabor y experiencia sensorial mejorados. MX2019002334A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662382319P 2016-09-01 2016-09-01
PCT/US2017/049618 WO2018045170A1 (en) 2016-09-01 2017-08-31 Medication with improved taste and sensory experience

Publications (1)

Publication Number Publication Date
MX2019002334A true MX2019002334A (es) 2019-05-16

Family

ID=59982464

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002334A MX2019002334A (es) 2016-09-01 2017-08-31 Medicamentos con sabor y experiencia sensorial mejorados.

Country Status (7)

Country Link
US (1) US20180055938A1 (es)
EP (1) EP3506885A1 (es)
CN (1) CN109640956B (es)
AU (1) AU2017321700A1 (es)
CA (1) CA3032750C (es)
MX (1) MX2019002334A (es)
WO (1) WO2018045170A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110327339A (zh) * 2019-08-07 2019-10-15 北京博达绿洲医药科技研究有限公司 一种复方右美沙芬口服溶液及其制备方法和用途
CN116832038A (zh) * 2020-11-24 2023-10-03 四川逢春制药有限公司 一种复方口服溶液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US20030104038A1 (en) * 2000-07-07 2003-06-05 The Procter & Gamble Company Cough treatment
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
US20070160689A1 (en) * 2006-01-12 2007-07-12 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
WO2007089652A2 (en) * 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20080014274A1 (en) * 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
US20120264776A1 (en) * 2011-03-31 2012-10-18 Jitendra Krishan Somani Menthol liquids composition
BR102012033020A2 (pt) * 2011-12-22 2015-10-20 Int Flavors & Fragrances Inc composições para aumento da sensação de frescor
WO2014127118A1 (en) * 2013-02-13 2014-08-21 The Procter & Gamble Company Anise flavored medication
WO2014132163A1 (en) * 2013-02-28 2014-09-04 Pfizer Inc. Enhanced stability of novel liquid compositions
US20150307447A1 (en) * 2014-04-23 2015-10-29 The Procter & Gamble Company Compositions for deposition on biological surfaces

Also Published As

Publication number Publication date
CN109640956B (zh) 2022-05-13
AU2017321700A1 (en) 2019-02-07
CA3032750A1 (en) 2018-03-08
US20180055938A1 (en) 2018-03-01
WO2018045170A1 (en) 2018-03-08
CA3032750C (en) 2021-04-13
CN109640956A (zh) 2019-04-16
EP3506885A1 (en) 2019-07-10

Similar Documents

Publication Publication Date Title
IL267537B (en) New converted indazoles, processes for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicines
EP3558420A4 (en) DRUG DELIVERY DEVICE AND METHODS OF DELIVERY OF DRUGS TO INFANTS AND CHILDREN
MX2023000320A (es) Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion.
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
CL2016002132A1 (es) Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo.
GT201600142A (es) Composiciones farmacéuticas que comprenden azd9291
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
WO2015165413A8 (zh) 一种新型的稳定型抗体药物耦联物及其制备方法和用途
IL291521A (en) An injection device, especially an automatic injector, for the simultaneous administration of several drugs
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
MD20150053A2 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
MX2019002334A (es) Medicamentos con sabor y experiencia sensorial mejorados.
MX2014003219A (es) Sistema de cierre de inyeccion.
MX2021001845A (es) Un medicamento combinado que comprende fenilefrina y paracetamol.
CL2018002461A1 (es) Composiciones farmacéuticas disuasivas del abuso.
JP2016513680A5 (es)
JP2016513537A5 (es)
NZ702849A (en) Genotype- or phenotype-based drug formulation
IN2013MU03370A (es)
EA201692426A1 (ru) Комбинации зальтопрофена и миорелаксанта
郝景萌 Connecting the GRB rate and the cosmic star formation history: Implications for the progenitors of GRBs
EP3661486A4 (en) PHARMACEUTICAL COMPOSITION CONSISTING OF TETROFOSMINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
Ruizhuang et al. The changing world order and China
CR20150363A (es) Combinación de un medicamento que comprende fenilefrina y paracetamol
李尚活 IRAM 30m Mapping of Massive Star Forming Regions